A fiber-modified adenoviral vector interacts with immunoevasion molecules of the B7 family at the surface of murine leukemia cells derived from dormant tumors

Molecular Cancer

Volumn 10, Issue , 2011, Pages

  Grellier, Elodie ^a,b,c   Lécolle, Katia ^a,b,c   Rogée, Sophie ^a,b,c   Couturier, Cyril ^b,d   D'Halluin, Jean Claude ^a,c   Hong, Saw See ^e   Fender, Pascal ^f   Boulanger, Pierre ^e   Quesnel, Bruno ^a,b,c,g   Colin, Morvane ^a,b,c  

^a JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^b UNIV LILLE   (France)

^c Institut de Recherche sur le Cancer de Lille   (France)

^d INSERM   (France)

^e UNIVERSITÉ LYON 1   (France)

^f EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Adenovirus; Adenovirus vector; Atadenovirus; B7 H1; B7.1; Chimeric fiber; Dormant leukemia cells

Indexed keywords

ADENOVIRUS VECTOR; B7 ANTIGEN; B7.1 ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1; UNCLASSIFIED DRUG; CAPSID PROTEIN; RECOMBINANT PROTEIN; VIRUS PROTEIN;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CELL POPULATION; DORMANCY; FLOW CYTOMETRY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNE EVASION; IMMUNE SYSTEM; INTERNALIZATION; LEUKEMIA CELL; ADENOVIRUS; ANIMAL; GENE SILENCING; GENE TRANSFER; GENE VECTOR; GENETICS; LEUKEMIA; METABOLISM; MOUSE; PROTEIN BINDING; PROTEIN MULTIMERIZATION; SURFACE PLASMON RESONANCE; TUMOR CELL LINE; TUMOR ESCAPE; VIRUS ATTACHMENT; VIRUS ENTRY;

ADENOVIRIDAE; ATADENOVIRUS; BOVINAE; HUMAN ADENOVIRUS; MURINAE;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD274; ANTIGENS, CD80; CAPSID PROTEINS; CELL LINE, TUMOR; GENE KNOCKDOWN TECHNIQUES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LEUKEMIA; MICE; PROTEIN BINDING; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; SURFACE PLASMON RESONANCE; TUMOR ESCAPE; VIRAL TAIL PROTEINS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 80052148008     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-10-105     Document Type: Article

References (49)

1. Lang TJ, Nguyen P, Peach R, Gause WC, Via CS. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J Immunol 2002, 168:3786-3792.
2. Saverino D, Tenca C, Zarcone D, Merlo A, Megiovanni AM, Valle MT, Manca F, Grossi CE, Ciccone E. CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion. J Immunol 1999, 162:651-658.
3. Tirapu I, Huarte E, Guiducci C, Arina A, Zaratiegui M, Murillo O, Gonzalez A, Berasain C, Berraondo P, Fortes P, et al. Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma. Cancer Res 2006, 66:2442-2450. 10.1158/0008-5472.CAN-05-1681, 16489051.
4. Zhou P, Zheng X, Zhang H, Liu Y, Zheng P. B7 blockade alters the balance between regulatory T cells and tumor-reactive T cells for immunotherapy of cancer. Clin Cancer Res 2009, 15:960-970. 10.1158/1078-0432.CCR-08-1611, 2693886, 19188167.
5. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000, 192:1027-1034. 10.1084/jem.192.7.1027, 2193311, 11015443.
6. Butte MJ, Pena-Cruz V, Kim MJ, Freeman GJ, Sharpe AH. Interaction of human PD-L1 and B7-1. Mol Immunol 2008, 45:3567-3572. 10.1016/j.molimm.2008.05.014, 18585785.
7. Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002, 8:793-800.
8. Liu J, Hamrouni A, Wolowiec D, Coiteux V, Kuliczkowski K, Hetuin D, Saudemont A, Quesnel B. Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway. Blood 2007, 110:296-304. 10.1182/blood-2006-10-051482, 17363736.
9. Zou W, Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 2008, 8:467-477. 10.1038/nri2326, 18500231.
10. Saudemont A, Hamrouni A, Marchetti P, Liu J, Jouy N, Hetuin D, Colucci F, Quesnel B. Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1. Cancer Res 2007, 67:4491-4498. 10.1158/0008-5472.CAN-06-1627, 17483365.
11. Saudemont A, Jouy N, Hetuin D, Quesnel B. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 2005, 105:2428-2435. 10.1182/blood-2004-09-3458, 15536145.
12. Saudemont A, Quesnel B. In a model of tumor dormancy, long-term persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis. Blood 2004, 104:2124-2133. 10.1182/blood-2004-01-0064, 15191948.
13. Quesnel B. Tumor dormancy and immunoescape. APMIS 2008, 116:685-694. 10.1111/j.1600-0463.2008.01163.x, 18834412.
14. Chames P, Van Regenmortel M, Weiss E, Baty D. Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol 2009, 157:220-233. 10.1111/j.1476-5381.2009.00190.x, 2697811, 19459844.
15. Campos SK, Barry MA. Current advances and future challenges in adenoviral vector biology and targeting. Curr Gene Ther 2007, 7:189-204. 10.2174/156652307780859062, 2244792, 17584037.
16. Hendrie PC, Russell DW. Gene targeting with viral vectors. Review. Mol Ther 2005, 12:9-17. 10.1016/j.ymthe.2005.04.006, 15932801.
17. Russell WC. Update on adenovirus and its vectors. J Gen Virol 2000, 81:2573-2604.
18. Russell WC. Adenoviruses: update on structure and function. J Gen Virol 2009, 90:1-20. 10.1099/vir.0.003087-0, 19088268.
19. Short JJ, Vasu C, Holterman MJ, Curiel DT, Pereboev A. Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors. Virus Res 2006, 122:144-153. 10.1016/j.virusres.2006.07.009, 2203219, 16920215.
20. Ulasov IV, Rivera AA, Han Y, Curiel DT, Zhu ZB, Lesniak MS. Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells. J Neurosurg 2007, 107:617-627. 10.3171/JNS-07/09/0617, 17886563.
21. Law LK, Davidson BL. What does it take to bind CAR?. Mol Ther 2005, 12:599-609. 10.1016/j.ymthe.2005.05.017, 16109509.
22. Wang H, Li ZY, Liu Y, Persson J, Beyer I, Möller T, Koyuncu D, Drescher MR, Strauss R, Zhang XB, et al. Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med 2011, 17:96-104. 10.1038/nm.2270, 3074512, 21151137.
23. Renaut L, Bernard C, D'Halluin J-C. A rapid and easy method for production and selection of recombinant adenovirus genomes. J Virol Methods 2002, 100:121-131. 10.1016/S0166-0934(01)00407-4, 11742659.
24. Renaut L, Colin M, Leite JP, Benko M, D'Halluin J-C. Abolition of hCAR-dependent cell tropism using fiber knobs of Atadenovirus serotypes. Virology 2004, 321:189-204. 10.1016/j.virol.2003.12.023, 15051380.
25. Rogée S, Grellier E, Bernard C, Colin M, D'Halluin J-C. Non-heparan sulfate GAG-dependent infection of cells using an adenoviral vector with a chimeric fiber conserving its KKTK motif. Virology 2008, 380:R60-68.
26. Rogée S, Grellier E, Bernard C, Jouy N, Loyens A, Beauvillain JC, Fender P, Corjon S, Hong SS, Boulanger P, et al. Influence of chimeric human-bovine fibers on adenoviral uptake by liver cells and the antiviral immune response. Gene Ther 2010, 17:880-891. 10.1038/gt.2010.37, 20393506.
27. Rogée S, Grellier E, Bernard C, Loyens A, Beauvillain J-C, D'Halluin J-C, Colin M. Intracellular trafficking of a fiber-modified adenovirus using lipid raft/caveolae endocytosis. Mol Ther 2007, 15:1963-1972. 10.1038/sj.mt.6300283, 17712334.
28. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 2002, 169:5538-5545.
29. Kamal M, Marquez M, Vauthier V, Leloire A, Froguel P, Jockers R, Couturier C. Improved donor/acceptor BRET couples for monitoring beta-arrestin recruitment to G protein-coupled receptors. Biotechnol J 2009, 4:1337-1344. 10.1002/biot.200900016, 19557797.
30. Mailly L, Renaut L, Rogée S, Grellier E, D'Halluin J-C, Colin M. Improved gene delivery to B lymphocytes using a modified adenovirus vector targeting CD21. Mol Ther 2006, 14:293-304. 10.1016/j.ymthe.2006.03.017, 16735140.
31. Boulanger P, Puvion F. Large-scale preparation of soluble adenovirus hexon, penton and fiber antigens in highly purified form. Eur J Biochem 1973, 39:37-42. 10.1111/j.1432-1033.1973.tb03100.x, 4203745.
32. Franqueville L, Henning P, Magnusson MK, Vigne E, Schoehn G, Blair-Zajdel ME, Habib N, Lindholm L, Blair GE, Hong SS, Boulanger P. Protein crystals in adenovirus type 5-infected cells: requirements for intranuclear crystallogenesis, structural and functional analysis. PLoS One 2008, 3:e2894. 10.1371/journal.pone.0002894, 2488365, 18682854.
33. Molinier-Frenkel V, Lengagne R, Gaden F, Hong SS, Choppin J, Gahery-Segard H, Boulanger P, Guillet J-G. Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J Virol 2002, 76:127-135. 10.1128/JVI.76.1.127-135.2002, 135719, 11739678.
34. Molinier-Frenkel V, Prévost-Blondel A, Hong SS, Lengagne R, Boudaly S, Magnusson MK, Boulanger P, Guillet J-G. The maturation of murine dendritic cells induced by human Adenovirus is mediated by the fiber knob domain. J Biol Chem 2003, 278:37175-37182. 10.1074/jbc.M303496200, 12855705.
35. Ayoub MA, Levoye A, Delagrange P, Jockers R. Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol Pharmacol 2004, 66:312-321. 10.1124/mol.104.000398, 15266022.
36. Bacart J, Corbel C, Jockers R, Bach S, Couturier C. The BRET technology and its application to screening assays. Biotechnol J 2008, 3:311-324. 10.1002/biot.200700222, 18228541.
37. Nishimura H, Honjo T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 2001, 22:265-268. 10.1016/S1471-4906(01)01888-9, 11323285.
38. Kocan M, See HB, Seeber RM, Eidne KA, Pfleger KD. Demonstration of improvements to the bioluminescence resonance energy transfer (BRET) technology for the monitoring of G protein-coupled receptors in live cells. J Biomol Screen 2008, 13:888-898. 10.1177/1087057108324032, 18812574.
39. Shimozono S, Miyawaki A. Engineering FRET constructs using CFP and YFP. Methods Cell Biol 2008, 85:381-393.
40. Bhatia S, Sun K, Almo SC, Nathenson SG, Hodes RJ. Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation. J Immunol 2010, 184:1821-1828. 10.4049/jimmunol.0902869, 20065109.
41. Schwartz JC, Zhang X, Nathenson SG, Almo SC. Structural mechanisms of costimulation. Nat Immunol 2002, 3:427-434. 10.1038/ni0502-427, 11976720.
42. Boute N, Pernet K, Issad T. Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer. Mol Pharmacol 2001, 60:640-645. 640-645.
43. Fender P, Ruigrok RW, Gout E, Buffet S, Chroboczek J. Adenovirus dodecahedron, a new vector for human gene transfer. Nat Biotechnol 1997, 15:52-56. 10.1038/nbt0197-52, 9035106.
44. Fender P, Schoehn G, Foucaud-Gamen J, Gout E, Garcel A, Drouet E, Chroboczek J. Adenovirus dodecahedron allows large multimeric protein transduction in human cells. J Virol 2003, 77:4960-4964. 10.1128/JVI.77.8.4960-4964.2003, 152161, 12663801.
45. Fender P, Schoehn G, Perron-Sierra F, Tucker GC, Lortat-Jacob H. Adenovirus dodecahedron cell attachment and entry are mediated by heparan sulfate and integrins and vary along the cell cycle. Virology 2008, 371:155-164. 10.1016/j.virol.2007.09.026, 17950396.
46. Gout E, Schoehn G, Fenel D, Lortat-Jacob H, Fender P. The adenovirus type 3 dodecahedron's RGD loop comprises an HSPG binding site that influences integrin binding. J Biomed Biotechnol 2010, e541939.
47. Hong SS, Gay B, Karayan L, Dabauvalle MC, Boulanger P. Cellular uptake and nuclear delivery of recombinant adenovirus penton base. Virology 1999, 262:163-177. 10.1006/viro.1999.9864, 10489350.
48. Gaden F, Franqueville L, Magnusson MK, Hong SS, Merten MD, Lindholm L, Boulanger P. Gene transduction and cell entry pathway of fiber-modified Adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells. J Virol 2004, 78:7227-7247. 10.1128/JVI.78.13.7227-7247.2004, 421659, 15194799.
49. Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, et al. Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci USA 2004, 101:17174-17179. 10.1073/pnas.0406351101, 534606, 15569934.